Authors

Joseph Park, PhD

Joseph Park, PhD, is the senior manager of regulatory strategy and policy at Samsung Bioepis. Park obtained his PhD from the Korea Advanced Institute of Science and Technology.

Justina Petrullo

Lana Pine

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

Peter Pitts

Peter Pitts is president and co-founder of the Center for Medicine in the Public Interest. He also serves as a visiting professor at the University of Paris School of Medicine. Pitts is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. He is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines.

Dracey Poore

Dracey Poore is the director of biosimilars at Cardinal Health. She is also a member of The Center for Biosimilars

Juliana M. Reed

Benjamin N. Rome, MD, MPH

Kristi Rosa

Tyler Sandahl, PharmD

Tyler Sandahl, PharmD, is a clinical pharmacist at Mayo Clinic.

Cameron Santoro

Cameron Santoro is an associate editor for The Center for Biosimilars